Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer

Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer—INCAGI004

Published:2022-04-29 Issue:8 Volume:30 Page:6557-6572
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Araujo Rodrigo Otavio,Vieira Fernando Meton,Victorino Ana Paula,Torres Claudia,Martins Ivanir,Guaraldi Simone,Valadão Marcus,Linhares Eduardo,Ferreira Carlos Gil,Thuler Luiz Claudio

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-022-07059-6.pdf

Reference60 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians [Internet]. 2018 [cited 2020 Dec 5];68(6):394–424. Available from: https://pubmed.ncbi.nlm.nih.gov/30207593/

2. Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2018: incidência de câncer no Brasil. Rio de Janeiro, Brazil: INCA; 2017. 128 p

3. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR et al (2017) AJCC Cancer Staging Manual (8th edition), 8th edn. Springer International Publishing, American Joint Commission on Cancer

4. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–40. https://doi.org/10.1056/NEJMoa040694

5. Hofheinz R-D, Wenz F, Post S, Matzdorff A, Laechelt S, Hartmann JT et al (2012) Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol 13(6):579–588

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of Life and Real-Time Patient Experience During Neoadjuvant Therapy;Annals of Surgery;2023-08-29